Shexiang Tongxin Dropping Pill for Coronary Microvascular Disease: Rationale and Design of a Multicenter Randomized Trial with a Cardiopulmonary Exercise Testing Primary Endpoint and AI-Enhanced Myocardial Contrast Echocardiograph - Report - MDSpire

Shexiang Tongxin Dropping Pill for Coronary Microvascular Disease: Rationale and Design of a Multicenter Randomized Trial with a Cardiopulmonary Exercise Testing Primary Endpoint and AI-Enhanced Myocardial Contrast Echocardiograph

  • By

  • Su, Meiyi

  • Tang, Yuqing

  • Sun, Pengtao

  • Cen, Huan

  • Liu, Shaonan

  • Li, Xianlun

  • Wang, Wei

  • Wang, Lei

  • June 10, 2026

  • 0 min

Share

Evaluation of Shexiang Tongxin Dropping Pill in Treating Coronary Microvascular Disease

Overview

{'add': 'Significance of cardiopulmonary exercise testing as a primary outcome measure.'}

Background

{'add': 'Details on current treatment options for CMVD.'}

Data Highlights

{'edit': 'Use consistent terminology for CPET.'}

Key Findings

{'add': 'Specific results from preliminary studies on STDP.'}

Clinical Implications

{'add': 'Discussion on limitations of STDP implementation.'}

Conclusion

{'add': 'Importance of findings in existing literature.'}

Related Resources & Content

  1. Frontiers in Cardiovascular Medicine, 2026 -- Efficacy and safety of Shenqi Yangxin formula in patients with stable coronary artery disease based on CCTA: rationale, design, and study protocol for a randomized, double-blind, placebo-controlled study
  2. Clinical Research in Cardiology, 2009 -- Presentations from the American College of Cardiology Congress 2009 on Hotline Sessions
  3. Intensive Care Medicine, 2023 -- Evaluation of Microcirculatory Function in Shock: Results from a Multicenter Randomized Controlled Trial
  4. Clinical Research in Cardiology, 2022 -- The Role of Gut Microbiota-Derived Trimethylamine N-oxide (TMAO) in Cardiovascular Risk Among Patients with Suspected Functionally Relevant Coronary Artery Disease (fCAD)
  5. State of the Art: Evaluation & Medical Management of Non-Obstructive Coronary Artery Disease in Patients with Chest Pain - Professional Heart Daily | American Heart Association
  6. WARRIOR: Intensive Medical Therapy vs. Usual Care in Women With Suspected INOCA - American College of Cardiology
  7. Quantification of myocardial blood flow using PET: Current status, clinical applications, and future directions
  8. State of the Art: Evaluation & Medical Management of Non-Obstructive Coronary Artery Disease in Patients with Chest Pain - Professional Heart Daily | American Heart Association
  9. WARRIOR: Intensive Medical Therapy vs. Usual Care in Women With Suspected INOCA - American College of Cardiology
  10. Quantification of myocardial blood flow using PET: Current status, clinical applications, and future directions

Original Source(s)

Shexiang Tongxin Dropping Pill for Coronary Microvascular Disease: Rationale and Design of a Multicenter Randomized Trial with a Cardiopulmonary Exercise Testing Primary Endpoint and AI-Enhanced Myocardial Contrast Echocardiograph

  • by Su, Meiyi , Tang, Yuqing , Sun, Pengtao , Cen, Huan , Liu, Shaonan , Li, Xianlun , Wang, Wei , Wang, Lei

  • June 10, 2026

Related Content

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

Functional consequences of diminished myocardial oxygen delivery per beat in experimental heart failure

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.